Leisman DE, Mehta A, Thompson BT, Charland NC, Gonye ALK, Gushterova I, Kays KR, Khanna HK, LaSalle TJ, Lavin-Parsons KM, et al. Alveolar, endothelial, and organ injury marker dynamics in severe COVID-19. Am J Respir Crit Care Med. 2021;205:507–19.
Article
PubMed Central
Google Scholar
Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, Hirayama AV, Mastroiani F, Turtle CJ, Harhay MO, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8(12):1233–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, et al. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 2021. https://doi.org/10.1172/jci.insight.144455.
Article
PubMed
PubMed Central
Google Scholar
Calvet J, Berenguer-Llergo A, Gay M, Massanella M, Domingo P, Llop M, Sanchez-Jimenez E, Arevalo M, Carrillo J, Albinana N, et al. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Sci Rep. 2022;12(1):640.
Article
CAS
PubMed
PubMed Central
Google Scholar
Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger T. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146(1):128-136 e124.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Magleby R, Westblade LF, Trzebucki A, Simon MS, Rajan M, Park J, Goyal P, Safford MM, Satlin MJ. Impact of severe acute respiratory syndrome coronavirus 2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019. Clin Infect Dis. 2021;73(11):e4197–205.
Article
CAS
PubMed
Google Scholar
Knudtzen FC, Jensen TG, Lindvig SO, Rasmussen LD, Madsen LW, Hoegh SV, Bek-Thomsen M, Laursen CB, Nielsen SL, Johansen IS. SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: a prospective cohort study. PLoS ONE. 2021;16(10):e0258421.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boyapati A, Wipperman MF, Ehmann PJ, Hamon S, Lederer DJ, Waldron A, Flanagan JJ, Karayusuf E, Bhore R, Nivens MC, et al. Baseline severe acute respiratory syndrome viral load is associated with coronavirus disease 2019 severity and clinical outcomes: post hoc analyses of a phase 2/3 trial. J Infect Dis. 2021;224(11):1830–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
de la Calle C, Lalueza A, Mancheno-Losa M, Maestro-de la Calle G, Lora-Tamayo J, Arrieta E, Garcia-Reyne A, Losada I, de Miguel B, Diaz-Simon R, et al. Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(6):1209–16.
Article
PubMed
PubMed Central
CAS
Google Scholar
Salto-Alejandre S, Berastegui-Cabrera J, Camacho-Martinez P, Infante-Dominguez C, Carretero-Ledesma M, Crespo-Rivas JC, Marquez E, Lomas JM, Bueno C, Amaya R, et al. SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome. Sci Rep. 2021;11(1):12931.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493.
Article
CAS
PubMed
PubMed Central
Google Scholar
Activ-Tico Bamlanivimab Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, et al. Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels : a randomized controlled trial. Ann Intern Med. 2022;175(2):234–43.
Article
Google Scholar
Berastegui-Cabrera J, Salto-Alejandre S, Valerio M, Perez-Palacios P, Revillas FAL, Abelenda-Alonso G, Oteo-Revuelta JA, Carretero-Ledesma M, Munoz P, Pascual A, et al. SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load. J Infect. 2021;82(3):e38–41.
Article
CAS
PubMed
Google Scholar
Chen L, Wang G, Long X, Hou H, Wei J, Cao Y, Tan J, Liu W, Huang L, Meng F, et al. Dynamics of blood viral load is strongly associated with clinical outcomes in coronavirus disease 2019 (COVID-19) patients: a prospective cohort study. J Mol Diagn. 2021;23(1):10–8.
Article
PubMed
CAS
Google Scholar
Hagman K, Hedenstierna M, Gille-Johnson P, Hammas B, Grabbe M, Dillner J, Ursing J. Severe acute respiratory syndrome coronavirus 2 rna in serum as predictor of severe outcome in coronavirus disease 2019: a retrospective cohort study. Clin Infect Dis. 2021;73(9):e2995–3001.
Article
CAS
PubMed
Google Scholar
Andersson MI, Arancibia-Carcamo CV, Auckland K, Baillie JK, Barnes E, Beneke T, Bibi S, Brooks T, Carroll M, Crook D, et al. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020;5:181.
Article
PubMed
PubMed Central
Google Scholar
Veyer D, Kerneis S, Poulet G, Wack M, Robillard N, Taly V, L’Honneur AS, Rozenberg F, Laurent-Puig P, Belec L, et al. Highly sensitive quantification of plasma severe acute respiratory syndrome coronavirus 2 RNA sheds light on its potential clinical value. Clin Infect Dis. 2021;73(9):e2890–7.
Article
CAS
PubMed
Google Scholar
Bermejo-Martin JF, Gonzalez-Rivera M, Almansa R, Micheloud D, Tedim AP, Dominguez-Gil M, Resino S, Martin-Fernandez M, Ryan Murua P, Perez-Garcia F, et al. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care. 2020;24(1):691.
Article
PubMed
PubMed Central
Google Scholar
Prebensen C, Myhre PL, Jonassen C, Rangberg A, Blomfeldt A, Svensson M, Omland T, Berdal JE. Severe acute respiratory syndrome coronavirus 2 RNA in plasma is associated with intensive care unit admission and mortality in patients hospitalized with coronavirus disease 2019. Clin Infect Dis. 2021;73(3):e799–802.
Article
CAS
PubMed
Google Scholar
Heinrich F, Nentwich MF, Bibiza-Freiwald E, Norz D, Roedl K, Christner M, Hoffmann A, Olearo F, Kluge S, Aepfelbacher M, et al. SARS-CoV-2 blood RNA load predicts outcome in critically Ill COVID-19 patients. Open Forum Infect Dis. 2021;8(11):ofab509.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(8):1937–42.
Article
CAS
PubMed
Google Scholar
Jacobs JL, Bain W, Naqvi A, Staines B, Castanha PMS, Yang H, Boltz VF, Barratt-Boyes S, Marques ETA, Mitchell SL, et al. SARS-CoV-2 viremia is associated with COVID-19 severity and predicts clinical outcomes. Clin Infect Dis. 2021;74(9):1525–33. https://doi.org/10.1093/cid/ciab686.
Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, Beaudoin-Bussieres G, Pagliuzza A, Gasser R, Benlarbi M, et al. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Sci Adv. 2021;7(48):eabj5629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nijhuis RHT, Russcher A, de Jong GJ, Jong E, Herder GJM, Remijn JA, Verweij SP. Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department. J Clin Virol. 2020;133:104655.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang K, Wu L, Luo Y, Gong B. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019. J Med Virol. 2021;93(5):3165–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ahava MJ, Kurkela S, Kuivanen S, Lappalainen M, Jarva H, Jaaskelainen AJ. Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection. J Virol Methods. 2022;302:114469.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, et al. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives. Clin Microbiol Infect. 2020;27(5):789.e1–5. https://doi.org/10.1016/j.cmi.2020.11.025.
Deng Q, Ye G, Pan Y, Xie W, Yang G, Li Z, Li Y. High performance of SARS-Cov-2N protein antigen chemiluminescence immunoassay as frontline testing for acute phase COVID-19 diagnosis: a retrospective cohort study. Front Med (Lausanne). 2021;8:676560.
Article
Google Scholar
Thudium RF, Stoico MP, Hogdall E, Hogh J, Krarup HB, Larsen MAH, Madsen PH, Nielsen SD, Ostrowski SR, Palombini A, et al. Early laboratory diagnosis of COVID-19 by antigen detection in blood samples of the SARS-CoV-2 nucleocapsid protein. J Clin Microbiol. 2021;59(10):e0100121.
Article
PubMed
Google Scholar
Shan D, Johnson JM, Fernandes SC, Suib H, Hwang S, Wuelfing D, Mendes M, Holdridge M, Burke EM, Beauregard K, et al. N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection. Nat Commun. 2021;12(1):1931.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sigal GB, Novak T, Mathew A, Chou J, Zhang Y, Manjula N, Bathala P, Joe J, Padmanabhan N, Romero D, et al. Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay. Clin Infect Dis. 2022;383:334.
Google Scholar
Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R, Mao CP, Newton G, Chang M, Nguyen K, et al. Ultra-sensitive serial profiling of SARS-CoV-2 antigens and antibodies in plasma to understand disease progression in COVID-19 patients with severe disease. Clin Chem. 2020;66(12):1562–72.
Article
PubMed
PubMed Central
Google Scholar
Martin-Vicente M, Almansa R, Martinez I, Tedim AP, Bustamante E, Tamayo L, Aldecoa C, Gomez JM, Renedo G, Berezo JA, et al. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients. J Intern Med. 2022;291(2):232–40.
Article
CAS
PubMed
Google Scholar
Olea B, Albert E, Torres I, Gozalbo-Rovira R, Carbonell N, Ferreres J, Poujois S, Costa R, Colomina J, Rodriguez-Diaz J, et al. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers. J Med Virol. 2022;94(1):222–8.
Article
CAS
PubMed
Google Scholar
Wang H, Hogan CA, Verghese M, Solis D, Sibai M, Huang C, Roltgen K, Stevens BA, Yamamoto F, Sahoo MK, et al. SARS-CoV-2 nucleocapsid plasma antigen for diagnosis and monitoring of COVID-19. Clin Chem. 2021;68(1):204–13.
Article
PubMed
PubMed Central
Google Scholar
Almansa R, Eiros JM, de Gonzalo-Calvo D, Postigo T, Ortega A, Lopez-Izquierdo R, Moncusi-Moix A, Gort-Paniello C, Dominguez-Gil M, Fuente A, et al. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: a prospective cohort study. Clin Microbiol Infect. 2022. https://doi.org/10.1016/j.cmi.2022.05.023.
Article
PubMed
PubMed Central
Google Scholar
Impacc Manuscript Writing Team, Committee INS. Immunophenotyping assessment in a COVID-19 cohort (IMPACC): a prospective longitudinal study. Sci Immunol. 2021. https://doi.org/10.1126/sciimmunol.abf3733.
Article
Google Scholar
Huang Z, Ning B, Yang HS, Youngquist BM, Niu A, Lyon CJ, Beddingfield BJ, Fears AC, Monk CH, Murrell AE, et al. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. J Clin Invest. 2021. https://doi.org/10.1172/JCI146031.
Article
PubMed
PubMed Central
Google Scholar
Kawasuji H, Morinaga Y, Tani H, Yoshida Y, Takegoshi Y, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, et al. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. J Med Virol. 2022;94(1):147–53.
Article
CAS
PubMed
Google Scholar
Brasen CL, Christensen H, Olsen DA, Kahns S, Andersen RF, Madsen JB, Lassen A, Kierkegaard H, Jensen A, Sydenham TV, et al. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19. Clin Chem Lab Med. 2021;59(12):1988–97.
Article
CAS
PubMed
Google Scholar
Fukuda Y, Tanaka A, Homma T, Kaneko K, Uno T, Fujiwara A, Uchida Y, Suzuki S, Kotani T, Sagara H. Utility of SpO2/FiO2 ratio for acute hypoxemic respiratory failure with bilateral opacities in the ICU. PLoS ONE. 2021;16(1):e0245927.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yamakawa N, Uchida T, Matthay MA, Makita K. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2011;300(4):L516-525.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wick KD, Siegel L, Neaton JD, Oldmixon C, Lundgren J, Dewar RL, Lane HC, Thompson BT, Matthay MA. RAGE has potential pathogenetic and prognostic value in non-intubated hospitalized patients with COVID-19. JCI Insight. 2022. https://doi.org/10.1172/jci.insight.157499.
Article
PubMed
PubMed Central
Google Scholar
Hue S, Beldi-Ferchiou A, Bendib I, Surenaud M, Fourati S, Frapard T, Rivoal S, Razazi K, Carteaux G, Delfau-Larue MH, et al. Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;202(11):1509–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Islam H, Chamberlain TC, Mui AL, Little JP. Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action? Front Immunol. 2021;12:677008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mick E, Kamm J, Pisco AO, Ratnasiri K, Babik JM, Castaneda G, DeRisi JL, Detweiler AM, Hao SL, Kangelaris KN, et al. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses. Nat Commun. 2020;11(1):5854.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cornelius M, Wang T, Jamal A, Loretan C, Neff L. Tobacco product use among adults: United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69:1736–42.
Article
PubMed
PubMed Central
Google Scholar
Tobacco use and exposure. http://www.sfhip.org/chna/community-health-data/tobacco-use-and-exposure/.
Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, van Bentum-Puijk W, Berry L, Bhimani Z, Bonten M, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA. 2020;324(13):1317–29.
Article
CAS
PubMed
PubMed Central
Google Scholar
Activ-Tico Ly- CoV555 Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, et al. A neutralizing monoclonal antibody for hospitalized patients with Covid-19. N Engl J Med. 2021;384(10):905–14.
Article
Google Scholar
Junqueira C, Crespo A, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022;606:576–84.
Article
CAS
PubMed
Google Scholar